In a mouse model of depression, fluoxetine reverses olfactory bulbectomy induced depressive behavior by increasing neurotransmitter acetylcholine activity in the limbic system [96] and alters CB1R expression pattern in the prefrontal cortex with chronic drug use [97]. This evidence concerns the gene CNR1 and depressive symptom measurement.